Dashenlin | Briefing, News, Analysis, Research, Data

Dashenlin

The company takes the development of pharmacy chain as the foundation of its business

Dashenlin Pharmaceutical Group Co. is a group enterprise integrating pharmaceutical production and sales. The company takes the development of pharmacy chain as the foundation of its business, and after many years of development, at the end of 2015, there were nearly 2,000 directly operated chain stores and nearly 18,000 employees.

Sector

Healthcare

Industry

Healthcare Services

Sub-industry

Founded

Feb 1, 1999

HQ location

Guangdong, China

Legal name

Dashenlin Pharmaceutical Group Co., Ltd.

Website

http://www.dslyy.com

DSL1999@dslyy.com

Employees

23854

All
News
Analysis
Research

Briefing Jun 24, 2022 11:15 AM · Healthcare

F-star to be acquired by China biopharmaceutical with USD 161million

Briefing Jun 24, 2022 11:07 AM · Healthcare

"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange

In-depth

Healthcare

MGI Tech: Lead Life Science Through Intelligent Innovation

In the dynamic realm of bioscience, MGI Tech Co., Ltd. (MGI) has emerged as a torchbearer, captivating attention with its trailblazing achievements and relentless dedication to innovation.

Sep 11, 2023 09:34 AM

Briefing Jun 24, 2022 10:59 AM · Healthcare | Technology

Herui gene launched the early screening product "quansining" for multiple cancer types, covering six high-risk cancer types

Briefing Jun 24, 2022 10:46 AM · Healthcare

East China medicine "liraglutide" goes to sea

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Technology, Consumer Staples

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Briefing Jun 23, 2022 06:25 PM · Healthcare

Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care

Briefing Jun 23, 2022 06:24 PM · Healthcare

Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing

Briefing Jun 23, 2022 10:36 AM · Healthcare

Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China

Briefing Jun 23, 2022 10:27 AM · Healthcare

Yanye new crown drug 3CL protein inhibitor has been suspended approval

Healthcare

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Apr 18, 2024 01:25 PM

Healthcare

Hengrui's MSCI ESG Rating Upgraded to A

Hengrui, as one of the leading pharmaceutical companies in innovation, has achieved continuous improvement in its MSCI ESG rating to "A" level, placing it at the forefront of the pharmaceutical industry in China.

Oct 08, 2023 12:28 PM

Briefing Jun 22, 2022 01:34 PM · Healthcare

Pharmaceutical business concept stocks quickly rose the first pharmaceutical trading limit

Briefing Mar 14, 2022 10:09 AM · Technology | Healthcare

Changes in the securities sector pulled up, and BOC securities rose by the limit

Briefing Mar 13, 2022 01:08 PM · Healthcare

The first batch of antigen testing agent boxes at the Shenzhen store of Da Shen Lin did not arrive. Wanfu biology was 19.3 yuan / time

Healthcare

Lanja has completed the Series A funding of hundred millions CNY

Shanghai Lanja Medical Technology Co., Ltd (“Lanja”) recently has announced the completion of the Series A funding of hundred millions CNY.

Sep 11, 2023 10:04 PM

Healthcare

RabPharma has completed the Series A+ funding of hundred millions CNY

Zhongshan RabPharma Biopharmaceutical Co., Ltd. (“RabPharma”) recently has announced the completion of the Series A+ funding of hundred millions CNY.

Sep 05, 2023 10:17 AM

Briefing Jan 19, 2022 10:40 AM · Healthcare | Industrials | Automotive

Midea Group: it will provide vehicle level solutions for new energy vehicles in the future

Briefing Dec 02, 2021 04:39 PM · Technology | Healthcare | Industrials

Nanwei shares: 3.432 million restricted shares will be unlocked for listing and circulation

Briefing Aug 16, 2021 04:10 PM · Technology | Healthcare

Da Shenlin: supervisors and executives did not reduce their shares in more than half of the reduction period

Briefing Aug 04, 2021 05:03 PM · Healthcare | Industrials | Automotive

Da Shenlin: the controlling shareholder pledged 860000 shares

EqualOcean Analysis